Selecta Biosciences Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,880.00
25,174.00
36,210.00
65,321.00
65,336
Depreciation, Depletion & Amortization
864.00
1,044.00
802.00
750.00
975
Other Funds
-
302.00
-
-
5,981
Funds from Operations
10,599.00
22,890.00
32,886.00
59,158.00
58,380
Changes in Working Capital
2,087.00
427.00
13,203.00
7,121.00
781
Net Operating Cash Flow
12,686.00
22,463.00
19,683.00
52,037.00
59,161
Capital Expenditures
227.00
1,163.00
586.00
733.00
Sale of Fixed Assets & Businesses
-
-
2.00
4.00
Purchase/Sale of Investments
-
-
28,416.00
1,369.00
Net Investing Cash Flow
227.00
4,679.00
22,100.00
2,098.00
Issuance/Reduction of Debt, Net
4,494.00
11,430.00
-
8,023.00
Net Financing Cash Flow
24,771.00
43,906.00
67,659.00
66,023.00
Net Change in Cash
8,535.00
15,745.00
26,319.00
11,966.00
Free Cash Flow
12,913.00
23,626.00
20,269.00
52,770.00
Other Sources
-
-
6,900.00
-
Change in Capital Stock
20,277.00
32,778.00
67,659.00
58,000.00
Exchange Rate Effect
3,323.00
1,019.00
443.00
78.00
Other Uses
-
3,516.00
-
-
About Selecta Biosciences
View Profile
